skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Resorcinol: Final goitrogenic product in water from a goitrogenic well

Journal Article · · [Formerly used by DOE/TIC for titles for which valid CODEN was not available. Now invalid] 92-DEC-15; (Country unknown/Code not available)
OSTI ID:6969353
;  [1];  [2]; ;  [3];  [4]
  1. Univ. of Mississippi, Jackson (United States) Veterans Administration Medical Center, Jackson, MS (United States)
  2. Oak Ridge National Lab., TN (United States)
  3. University of Alabama, Birmingham (United States) Veterans Administration Medical Center, Birmingham (United States)
  4. Vanderbilt Univ., Nashville, TN (United States)

In Candelaria, Colombia, SA, goiter prevalence among children was 23% in Zone A and 11% in Zone B (p <0.05). Socioeconomic conditions, dietary composition or iodine intake could not explain this difference. However, the water for the town was supplied by two wells through independent pipeline systems, one located in Zone A and the other in Zone B. Within a year, the goiter prevalence rose to 31% in Zone B, while that in Zone A remained the same, 26% (p,NS). This indicated that water from well A might contain goitrogens. Rats drinking water or activated carbon extracts from well A developed larger thyroid glands and more pronounced thiourea-like antithyroid effects than rats drinking water or extracts from well B. Similar results were obtained by the acute in vivo suppression of thyroid 131I-uptake in mice and by in vitro assays, Elemental analysis and infrared spectrometry of well A goitrogenic water extracts (GWE) gave composition and common absorption bands similar to those of aquatic humic substances (HS). The HS, fulvic and humic acids, inhibited thyroid peroxidase (TPO) in vitro with 15% of the potency of propylthiouracil (PTU). GC/MS analysis of GWE identified over 30 organic compounds, including resorcinol. In contrast only four compounds, not including resorcinol, were identified in well B non-GWE. Resorcinol was goitrogenic and antithyroid in two different rat strains.

DOE Contract Number:
AC05-84OR21400
OSTI ID:
6969353
Journal Information:
[Formerly used by DOE/TIC for titles for which valid CODEN was not available. Now invalid] 92-DEC-15; (Country unknown/Code not available), Vol. 5:4
Country of Publication:
United States
Language:
English

Similar Records

Resorcinol: Final goitrogenic product in water from a goitrogenic well
Conference · Mon Feb 01 00:00:00 EST 1988 · OSTI ID:6969353

Antithyroid effects of coal-derived pollutants
Journal Article · Tue Dec 01 00:00:00 EST 1992 · Journal of Toxicology and Environmental Health; (United States) · OSTI ID:6969353

Reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil
Journal Article · Thu Jun 01 00:00:00 EDT 1989 · Endocrinology; (United States) · OSTI ID:6969353